EPO published patent application EP4496538A1 (Publication A1) on March 25, 2026, for a prosthetic valve cardiac replacement system. The application covers prosthetic valve devices, catheter apparatus for minimally invasive delivery, and related surgical methods. Four inventors are listed: Roush, Eberhardt, Recber, and Thubrikar. The patent is classified under A61F 2/24 (prosthetic heart valves), A61M 25/00 (catheters), and A61F 2/95/966 (delivery systems).

This patent publication does not impose compliance obligations on medical device manufacturers. Competitors developing similar prosthetic valve technologies should review the claims to assess potential freedom-to-operate implications. The designated states include all major European Economic Area countries, giving the applicant potential enforcement rights across EU member states if the patent is granted after examination.